Mass High Tech
ACETYLON PHARMACEUTICALS INC
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
Acetylon is developing HDAC inhibiting small molecule drugs to treat cancer, autoimmune and other diseases.
Headlines from Mass High Tech about ACETYLON PHARMACEUTICALS INC
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2008 |
| Ownership Type | Private |
Contacts
| Walter Ogier | CEO | email available to subscribers | ||
| Simon Jones | VP Biology/Preclinical Dev't |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | Boston, MA |
| Website | http://www.acetylon.com |
| Revenue | Subscriber access only |
Contact Information
| Address | 70 Fargo St Suite 205 Boston, MA, 02210 |
| Phone | |
| Subscriber access only | |
| Website | www.acetylon.com |
New England Tech Directory
| Browse
| Subscribe
| Advertise
| Networking
| About Us
| Search
| 
RSS Feeds
| 
| Directory License
| Update User Info
| Directory Privacy Policy
| Logout
© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.